Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort
Chow, L. Q. M., Haddad, R., Gupta, S., Mahipal, A., Mehra, R., Tahara, M., Berger, R., Eder, J. P., Burtness, B., Lee, S.-H., Keam, B., Kang, H., Muro, K., Weiss, J., Geva, R., Lin, C.-C., Chung, H. CLanguage:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2016.68.1478
Date:
September, 2016
File:
PDF, 748 KB
english, 2016